Peripheral artery disease (PAD) of the lower extremities is a common manifestation of
atherosclerosis that is increasing in global prevalence and in the associated public health …

Peripheral arterial disease (PAD) is extremely prevalent, under-diagnosed and has a
tremendous impact on the quality of life of patients with this condition. The foundation of PAD …

Lower extremity peripheral arterial disease (PAD) affects approximately 10% of the
American population, with 30% to 40% of these patients presenting with claudication …

The lack of consistent definitions and nomenclature across clinical trials of novel devices,
drugs, or biologics poses a significant barrier to accrual of knowledge in and across …

The prevalence of peripheral artery disease (PAD) continues to increase worldwide. It is
important to identify patients with PAD because of the increased risk of myocardial infarction …

The treatment of peripheral artery disease (PAD) focuses on risk factor modification,
cardiovascular event reduction, limb viability, and symptom improvement. Hypertension …

Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis. Modifiable
risk factors including cigarette smoking, dyslipidemia, diabetes, poor diet quality, obesity …

Lower extremity peripheral artery disease (PAD) affects 12% to 20% of Americans 60 years
and older. The most significant risk factors for PAD are hyperlipidemia, hypertension …

Peripheral artery disease (PAD) includes atherosclerosis of the aorta and lower extremities.
Affecting a large segment of the population, PAD is associated with impaired functional …

Lower extremity peripheral artery disease (PAD) affects> 230 million adults worldwide and is
associated with increased risk of various adverse clinical outcomes (other cardiovascular …